OBJECTIVES This study sought to describe the frequency and clinical impact of acute scaffold disruption and late strut discontinuity of the second-generation Absorb bioresorbable polymeric vascular scaffolds (Absorb BVS, Abbott Vascular, Santa Clara, California) in the ABSORB (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) cohort B study by optical coherence tomography (OCT) post-procedure and at 6, 12, 24, and 36 months.
F ully bioresorbable scaffolds are a novel approach for treatment of coronary narrowing that provides transient vessel support with drug delivery capability without the long-term limitations of metallic drug-eluting stents, such as permanent caging with either outward bulging (evagination) of the luminal wall outside of the "cage," or intracage neoatherosclerosis (1, 2) . By freeing the coronary artery from metallic caging, the vessel thereby recovers its pulsatility, and vasomotion becomes again responsive without any constraint to the biochemical milieu, the endothelial shear stress, and the physiological cyclic strain (3, 4) .
The technology has the potential to overcome many of the safety concerns associated with metallic drugeluting stents and could possibly even provide further clinical benefit (5) .
In bioresorbable scaffold (4, 6, 7) . In the subsequent ABSORB cohort B trial, the second generation of the Absorb BVS showed a low late loss of 0.19 mm without any reduction of the scaffold area at 6 months by intravascular ultrasound (IVUS) and optical coherence tomography (OCT) (8, 9) . At 12-month follow-up, the angiographic late loss was 0.27 AE 0.32 mm, with an unchanged scaffold area. In addition, vasomotion induced by ergonovine and acetylcholine followed by intracoronary nitrate became detectable again, suggesting that the scaffolds mechanical integrity had subsided.
At 24-month follow-up, the angiographic late loss remained stable (0.27 AE 0.20 mm) with a late enlargement of the scaffold that compensated for the neointimal growth as detected by OCT (10) (11) (12) .
However, a potential drawback of this new technology is the risk for disruption of the strut network when it is overexpanded. Historically, the phenomenon was documented for the first time in an anecdotal case from the ABSORB cohort A trial. A 3.0-mm scaffold was overexpanded with a 3.5-mm balloon, resulting in scaffold disruption as documented by OCT (7) . Due to the recurrence of anginal symptoms at 40 days, this patient underwent repeat revascularization despite an angiographically nonsignificant stenosis by quantitative coronary angiography (QCA) (diameter stenosis of 42%) (13) . It is important that this acute mechanical disruption, is distinguished from the structural discontinuity of the polymeric struts at a later stage, a biologically programmed process during the course of bioresorption (13) (14) (15) . within the treated segment. The main quantitative measurements (strut core area, strut area, lumen area, scaffold area, incomplete scaffold apposition area, and neointimal area) required different analysis rules than metallic stents (8, 9, 12, 20) . The thickness of the neointimal coverage was measured for every strut between the abluminal side of the strut core and the lumen. Because the strut thickness is approximately 150 mm, the strut was considered as covered whenever the thickness of the coverage was above this threshold value (8, 12) . In a silicon phantom, a 3.0-mm Absorb BVS scaffold was disrupted through inflation of a semicompliant balloon up to 4.3 mm in diameter. Optical coherence tomography (OCT) showed the following: more than 2 struts in the same angular sector with close contact (2 struts stacked) (A) or without any contact (overhung struts) (B).
RESULTS

Baseline characteristics are presented in Online
The other presentation of disrupted scaffold is the detection of an isolated malapposed strut located at the center of the lumen with loss of circularity of the scaffold (C).
The distance from the abluminal side of the strut to the luminal border should be more than one-third of the distance from the center of gravity to the lumen border in the corresponding angular sector. In the second case, a 3.0-mm scaffold was implanted in a small vessel with a reference vessel diameter Clinical events up to 2 yrs
Non-ischemia-driven target lesion revascularization None Values are n unless otherwise indicated. *The balloon diameter at maximal pressure is in a chart provided by the balloon manufacturer. †The quantitative assessment was not performed because in many cross sections, the complete luminal border was not visualized. ‡The quantitative assessment was not performed because the segment was covered by a metallic stent after non-ischemiadriven revascularization. Table 2 and Figure 4 . There were no differences in baseline characteristics between patients with or without late discontinuities except for the pre-procedural minimal lumen diameter and diameter stenosis, which could be a play of chance. On IVUS, late discontinuities were detected only in 3 cases.
In the series with 6-and 24-month follow-up, late discontinuities were observed in 3 cases at 6 months and were persistently observed at the second followup at 24 months (Online Figure 2) . In 8 cases, late discontinuities were observed only at 2 years.
FIGURE 3 An Example of Acute Disruption
Each series of framed illustrations (yellow, green, and blue) represents the observation at different time points (post-procedure, at 6 months, and at 2 years). An Absorb BVS scaffold was implanted in a small circumflex (reference vessel diameter 2.42 mm) (A) followed by post-dilation with a 3.0-mm noncompliant balloon at a maximal pressure of 24 atm (B). Post-procedural OCT detected overhung struts or isolated struts in 5 cross sections (C), which were not detected by IVUS (D). At 6-month followup, the patient underwent repeat angiography that revealed low angiographic late loss of 0.10 mm (E). According to the protocol, IVUS (F) and OCT were performed. IVUS did not detect any abnormality (G, H). After IVUS, the operator experienced difficulty crossing the scaffolded segment with the OCT catheter (I). After rewiring the scaffolded segment, OCT was successfully acquired and showed isolated struts close to the OCT catheter with loss of circularity of the scaffold (J, K, L: corresponding frames with G and H). resolution at 36 months of late acquired discontinuity originally detected at 12 months. Framed illustrations in red (D, E, F) correspond to a scaffold with persistent (at 36 months) late discontinuities detected at 12 months. In both cases, the stacked struts were already covered at 12 months. BL ¼ baseline, SB ¼ side-branch; other abbreviations as in Figures 1 and 2. balloon. Following the dilation, contrast retention was resolved.
DISCUSSION
The main findings of the current analysis are the following: 1) acute disruption induced by the procedure was observed in 2 of 51 patients (52 pullbacks, 3.9%), with 1 patient, it was presumably related to the TLR; 2) late resorption-related discontinuity was observed in 21 patients with 1, presumably nonrelated, non-ischemia-driven TLR; 3) QCA was unable to detect these structural changes, whereas IVUS was able to detect some of the major acute disruptions/late discontinuities (4 of 23 cases). The tensile strength of the poly-L-lactide is 50 to 70 MPa, whereas that of cobalt-chrome alloy or stainless steel is in the range of 668 to 1,449 MPa.
Percent of elongation at break is 2% to 10 % for poly-Llactide, whereas it is more than 40% for cobalt chromium or stainless steel. The expansion range of the polymeric device is therefore inherently limited (12) . showed that the thrombogenicity of polymeric struts is less than that of bare-metal struts, the possibility exists that a small thrombus could form around the isolated and malapposed struts. This is also sug- In fact, after 6 months, the polymeric scaffold starts losing its mechanical integrity and that can lead to expected late discontinuity. Figure 5 shows the progression of structural disintegration over time due to bioresorption. The spread-out view showed that postprocedure, the scaffold consisted of 19 rings connected to each other with 3 links, as manufactured. As shown in Figure 5 OCT was not available post-procedure, differentiation of persistent acute disruption from late discontinuities was speculative ( Table 1) . Stacked, overhung, or isolated malapposed struts with circular structure that were observed later than 6 months, especially when covered and apposed, could likely be attributed to late resorption-related discontinuities.
OCT AND IVUS. The current analysis showed that IVUS is less sensitive than OCT in the detection of acute strut disruption or late strut discontinuity.
IVUS was able to detect major disruptions or discontinuities, but overlooked some disruptions or could not differentiate them from malapposition 
